The global malaria vaccines market is expected to witness a CAGR of 102.8% during the forecast period (2018 – 2024). - PowerPoint PPT Presentation

Loading...

PPT – The global malaria vaccines market is expected to witness a CAGR of 102.8% during the forecast period (2018 – 2024). PowerPoint presentation | free to download - id: 87cf77-MmMyN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

The global malaria vaccines market is expected to witness a CAGR of 102.8% during the forecast period (2018 – 2024).

Description:

Global Malaria Vaccines Market, By Vaccines Type, Agent Distribution Channel and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024 – PowerPoint PPT presentation

Number of Views:6

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: The global malaria vaccines market is expected to witness a CAGR of 102.8% during the forecast period (2018 – 2024).


1
malaria vaccines market -
By Vaccines Type, Agent Distribution Channel and
Geography - Insights, Opportunity Analysis, and
Industry Forecast till 2024
2
The malaria vaccines market is pegged to be
valued at US 8.5 million in 2018 and is
projected to expand at a CAGR of 102.8 during
the forecast period (2018-2024), as highlighted
in a new report published by Coherent Market
Insights.Rise in demand for vaccines for
important indications on the backdrop of
increasing focus on biological preparations is
expected to be a major factor driving growth of
the global malaria vaccines market over the
foreseeable future. According to World Health
Organization (WHO) malaria fact sheet and World
Bank estimates, over 40 of the global population
is at risk of malaria. World Health Organization
(WHO), there were around 214 million malaria
cases reported in 2015, leading to 438,000 deaths
worldwide. Over 70 of these deaths were among
children under 5 years of age. Sub-Saharan Africa
accounts for the highest share of global malaria
burden, with around 89 of malaria cases and 91
of malarial deaths in 2015. Such high impact of
this life-threatening disease is influencing
governments across various countries, companies,
investors, and non-profit organizations to
contribute towards curbing spreading of this
disease. Since the problem of malaria is
burdening many of the emerging and under
developed regions such as in Africa and Asia
Pacific, various initiatives have been
implemented in these regions to drive down high
costs of the vaccine in development. For
instance, in 2016, GSK announced plans to develop
vaccines at a mere profit margin of 5 of the
cost of the vaccine. Governments across most
regions are actively involved in programs aimed
at eliminating malaria. For instance, WHO had
mobilized funding for pilot program in first
phase between 2017 and 2020 by the global fund to
fight against malaria and other disease such as
AIDS and tuberculosis prevalent worldwide.
3
Key takeaways of the malaria vaccines market The
global malaria vaccines market is expected to
expand at a CAGR of 102.8 during the forecast
period (20162024) as there exists a large
unrealized market especially in Africa, Asia
Pacific, Latin America and Middle EastThe
Pre-Erythrocytic Vaccine dominates the market in
the vaccines type segment, as it is used to
prevent the infection completely, while
blood-stage vaccines aim to reduce or eliminate
the parasite load once a person is
infected Plasmodium Falciparum is the major agent
segment of malaria vaccines market, as Plasmodium
falciparum infection are induced by the asexual
stages of the parasite that develop inside red
blood cells, making it one of most severe forms
of malaria among various types of parasites
causing malaria Some of the major players
involved in global malaria vaccines market are
GlaxoSmithKline plc, Sanaria Inc, Nobelpharma
Co., Ltd., Sumaya Biotech and GenVec,
Inc. Request Sample of Malaria Vaccines Market
https//www.coherentmarketinsights.com/insight/req
uest-sample/37
4
Shift from pharmaceutical oral dosage forms to
parenteral dosage forms is expected boost the
malaria vaccines market globally. The emerging
economies are undergoing a wave of various
healthcare reforms. Healthcare treatment regimens
are becoming more reliable for the growth of the
global market, with various initiatives in place
to eradicate the menace of malaria. In 2016, in
India, the National Framework for Malaria
Elimination (NFME), was launched to eliminate the
problem in the country. This program was based on
the Framework by the National Vector Borne
Disease Control Program (NVBDCP) of the Ministry
of Health and Family Welfare. According to NFME,
in 2012, the total economic burden of malaria in
India was around US 1,940 Mn, with 75 from lost
earnings and 25 from treatment costs borne by
households. According to World Malaria Report
2015, India accounts for around 70 of the total
malaria incidence rate in the South-East Asia. In
2014, the incidence rate of malaria in the
country was around 0.89 per 1,000 person at risk
per year. Around 1.1 Mn cases were reported,
which lead to 562 deaths in India in 2014. To Get
Discount On This Reporthttps//www.coherentmarket
insights.com/insight/request-discount/37
5
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market
intelligence and consulting organization focused
on assisting its plethora of clients achieve
transformational growth by helping them make
critical business decisions. We are headquartered
in India, with an office at the global financial
capital in the U.S. Our client base includes
players from across all business verticals in
over 150 countries worldwide. We are uniquely
positioned to help businesses around the globe
deliver practical and lasting results through
various recommendations about operational
improvements, technologies, emerging market
trends and new working methods. We offer both
customized and syndicated market research reports
that help our clients create visionary growth
plans to provide traction to their business. We
meticulously study emerging trends across various
industries at both the global and regional levels
to identify new opportunities for our clientele.
SERVICES
CUSTOMIZED RESEARCH
INDUSTRY ANALYSIS
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
6
ABOUT COHERENT MARKET INSIGHTS
Industries we cater
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
BIOTECHNOLOGY
HEALTHCARE IT
PHARMACEUTICAL
MEDICAL IMAGING
MEDICAL DEVICES
Chemicals Materials
Bulk Chemicals
Advanced Materials
Speciality and Fine Chemicals
Green Chemicals
Polymers Resins
Food Ingredients
Cosmetic Ingredients
7
ABOUT COHERENT MARKET INSIGHTS
RESEARCH SOLUTIONS
KEY STATS
GLOBAL REPORTS
FEASIBILITY STUDIES
100
Insights Published Per Year
COUNTRY ANALYSIS
150
CUSTOMIZED SOLUTIONS
CONSULT PROJECTS
Consulting Projects Till Date
SURVEY RESEARCH
EXCEL FORECAST DATABASE
125
COMPETITIVE ASSESSMENT
Clients Worldwide Per Year
110
TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering
unmatched actionable market intelligence across
various industry verticals, including chemicals,
healthcare, and food beverages, to name a few.
We implement holistic market research methodology
in order to result in the best possible market
research reports across various industries
worldwide. Based on our unmatched expertise
across various industriesno matter how large or
small, how complex or uniquewe help our clients
achieve better outcomes with uniquely designed
and highly customized solutions. Our coverage
includes insights that help our clients ensure
sustained growth in developed markets and also
key inputs to help them tap into emerging markets
and exploit the plethora of opportunities posed
therein.
8
THANK YOU
To know more about us, visit our website
www.coherentmarketinsights.com For sales
queries or new topics email us on
sales_at_coherentmarketinsights.com For other
queries contact Mr. Shah (Manager - Business Deve
lopment) Coherent Market Insights sales_at_coherentm
arketinsights.com 1-206-701-6702
About PowerShow.com